Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi

American Journal of Tropical Medicine and Hygiene

Volumn 68, Issue 4, 2003, Pages 413-415

  Mita, Toshihiro ^a   Kaneko, Akira ^a   Lum, J Koji ^a   Bwijo, Bwijo ^a   Takechi, Miho ^b   Zungu, Innocent L ^b   Tsukahara, Takahiro ^a   Tanabe, Kazuyuki ^c   Kobayakawa, Takatoshi ^a   Björkman, Anders ^d  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b MINISTRY OF HEALTH   (Malawi)

^c OSAKA INSTITUTE OF TECHNOLOGY   (Japan)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DNA; ABC TRANSPORTER; ANTIMALARIAL AGENT; MDR GENE PROTEIN, PLASMODIUM; MEMBRANE PROTEIN; PFCRT PROTEIN, PLASMODIUM FALCIPARUM; PROTOZOAL PROTEIN;

ADOLESCENT; ARTICLE; CHILD; DRUG EFFICACY; DRUG RESISTANCE; DRUG WITHDRAWAL; GENE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ANIMAL; DRUG EFFECT; DRUG SENSITIVITY; GENETIC POLYMORPHISM; GENETICS; INFANT; MALARIA FALCIPARUM; MALAWI; MULTIDRUG RESISTANCE; PARASITOLOGY; POINT MUTATION; PRESCHOOL CHILD;

PLASMODIUM FALCIPARUM; PROTOZOA;

ADOLESCENT; ANIMALS; ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALAWI; MEMBRANE PROTEINS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS;

EID: 0042808413     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2003.68.413     Document Type: Article

References (19)

1. Wernsdorfer WH, Payne D, 1991. The dynamics of drug resistance in Plasmodium falciparum. Pharmacol Ther 50: 95-121.
2. Gallup JL, Sachs JD, 2001. The economic burden of malaria. Am J Trop Med Hyg 64: 85-96.
3. Foote SJ, Thompson JK, Cowman AF, Kemp DJ, 1989. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57: 921-930.
4. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF, 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
5. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC, 2000. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol 108: 13-23.
6. Wellems TE, Panton LJ, Gluzman IY, do Rosario VE, Gwadz RW, Walker-Jonah A, Krogstad DJ, 1990. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345: 253-255.
7. von Seidlein L, Duraisingh MT, Drakeley CJ, Bailey R, Greenwood BM, Pinder M, 1997. Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. Trans R Soc Trop Med Hyg 91: 450-453.
8. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein Pfcrt and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
9. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D, 2001. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344: 257-263.
10. Dorsey G, Kamya MR, Singh A, Rosenthal PJ, 2001. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis 183: 1417-1420.
11. Mayor AG, Gomez-Olive X, Aponte JJ, Casimiro S, Mabunda S, Dgedge M, Barreto A, Alonso PL, 2001. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. J Infect Dis 183: 1413-1416.
12. Pillai DR, Labbe AC, Vanisaveth V, Hongvangthong B, Pomphida S, Inkathone S, Zhong K, Kain KC, 2001. Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis 183: 789-795.
13. Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC, 1993. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167: 932-937.
14. Takechi M, Matsuo M, Ziba C, MacHeso A, Butao D, Zungu IL, Chakanika I, Bustos MD, 2001. Therapeutic efficacy of sulphadoxine/pyrimethamine and susceptibility in vitro of P. falciparum isolates to sulphadoxine-pyremethamine and other antimalarial drugs in Malawian children. Trop Med Int Health 6: 429-434.
15. Sakihama N, Mitamura T, Kaneko A, Horii T, Tanabe K, 2001. Long PCR amplification of Plasmodium falciparum DNA extracted from filter paper blots. Exp Parasitol 97: 50-54.
16. Sokal RR, Rohlf FJ, 1995. Biometry: The Principles and Practice of Statistics in Biological Research. Third edition. New York: W. H. Freeman and Company.
17. Slutsker LM, Khoromana CO, Payne D, Allen CR, Wirima JJ, Heymann DL, Patchen L, Steketee RW, 1990. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Bull World Health Organ 68: 53-59.
18. Mshinda H, Font F, Hirt R, Mashaka M, Ascaso C, Menendez C, 1996. A comparative study of the efficacies of chloroquine and a pyrimethamine-dapsone combination in clearing Plasmodium falciparum parasitaemia in school children in Tanzania. Trop Med Int Health 1: 797-801.
19. Ariey F, Randrianarivelojosia M, Duchemin JB, Rakotondramarina D, Ouledi A, Robert V, Jambou R, Jahevitra M, Andrianantenaina H, Raharimalala L, Mauclere P, 2002. Mapping of a Plasmodium falciparum pfcrt K76T mutation: a useful strategy for controlling chloroquine resistance in Madagascar. J Infect Dis 185: 710-712.